Summary
Signal counts
Assets tracked: 4
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Yonsei University
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05908916 | https://clinicaltrials.gov/study/NCT07547592 | https://clinicaltrials.gov/study/NCT05280457 | https://clinicaltrials.gov/study/NCT01608022
Assets
Linked programs
- AtezoBev with combined radiotherapy: Timeline Staleness Signal (2/5)
- Bev + Gem + Doc: Low Signal (0/5)
- nivolumab-GX-188E-GX-I7: Low Signal (1/5)
- PF804: Results Not Found Signal (3/5)